Dr Jonathan Cohen-Gold
Dr Jonathan Cohen-Gold is Co-founder and CEO of Houdini Bio, a University of Cambridge spinout developing technology to improve the safety, durability and efficacy of cell and gene therapies.
He completed his scientific training at King's College London and the University of Cambridge, where his PhD research identified a way to prevent cells from switching off therapeutic DNA.
Jonathan also gained venture creation and investment experience at Deep Science Ventures, supporting the development of early-stage science companies. At Houdini Bio, he works alongside Co-founder Lee Dunham to translate this research into technologies for cell and gene therapy.
Contact info
- Website:
- https://www.houdinibio.com/
ArticleGene therapy’s biggest challenge is the cell’s own defence mechanisms
What if one of gene therapy’s biggest obstacles isn’t delivery, but the body’s own cells? Discover why DNA silencing is emerging as a major challenge for long-lasting genetic medicines.